Myriad Genetics | MYGN - Current Assets

Stock Price
4.78
Daily Change
-0.01 -0.21%
Monthly
2.14%
Yearly
-35.58%
Q2 Forecast
4.97

Myriad Genetics reported $332.6M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agilent USD 4.62B 21M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Danaher USD 13.94B 1.18B Mar/2026
Illumina USD 3.29B 493M Dec/2025
J&J USD 59.17B 3.55B Mar/2026
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Myriad Genetics USD 332.6M 12.2M Dec/2025
OraSure Technologies USD 261.91M 21.1M Dec/2025
Pacific Biosciences Of California USD 375.05M 19.18M Dec/2025
Quest Diagnostics USD 2.57B 188M Mar/2026
Quidel USD 1.45B 80.6M Dec/2025
Repligen USD 1.14B 40.9M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Standard Biotools USD 454.26M 18.18M Dec/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Veracyte USD 488.38M 39.15M Dec/2025
Waters USD 1.99B 69.86M Dec/2025